Linked from

The 20 pages that link to Cost-effectiveness analysis, each with the reason it gives.

• Cost–benefit analysisCompared with: It avoids pricing benefits when outcomes can be compared in natural units.

• Health technology assessmentBroader topic: It estimates whether additional health gains justify a technology’s additional costs.

• Effective altruismRelated: It helps estimate how much good different charitable interventions achieve for each dollar.

• Command-and-control regulationRelated: It helps assess whether prescribed controls meet regulatory goals at reasonable cost.

• Preventive medicineRelated: It helps assess whether preventive programs produce sufficient health gains for their costs.

• Program evaluationRelated: It helps determine whether measured benefits justify the resources required.

• Resource allocationCompared with: It prioritizes outcomes per unit of cost rather than distributing resources equally.

• AdditionalityCompared with: An intervention can be additional yet deliver its added outcome at high cost.

• Health economicsBroader topic: It expresses the central allocation problem as a comparison of added costs and health gains.

• Policy analysisRelated: It helps rank options when the goal is fixed but resources are limited.

• Marginal analysisRelated: It holds the outcome target in view rather than weighing all outcomes in monetary terms.

• Poverty reductionRelated: It helps assess how much poverty reduction a program produces per unit of spending.

• Disability-adjusted life yearRelated: Analysts can compare spending by the disability-adjusted life years averted.

• PCSK9 inhibitorsRelated: Drug prices and absolute cardiovascular benefit shape the value of PCSK9 treatment.

• Economic efficiencyCompared with: It evaluates least-cost achievement of a chosen goal, rather than overall value across all goals.

• Sacubitril/valsartanRelated: Its clinical gains must be weighed against acquisition costs and health-system budgets.

• Medical testRelated: It evaluates whether a test’s added health benefit justifies its resource use.

• WHO Model List of Essential MedicinesRelated: Comparative value helps assess medicines competing for limited health resources.

• Engineering economicsCompared with: It ranks ways to meet a target without requiring every benefit to be monetized.

• Healthcare policyRelated: It helps policymakers compare the value of competing health interventions.